🔓
Sign in as a Member to unlock the full view of HR.1414. · Full carveout list, all affected companies, party defectors, and 30-day trade predictions.
Become a Member$24.50/mo already a Member? Sign in →
HR.1414 · 119TH CONGRESS

Cameron’s Law

Status
In Committee
Latest Action
2025-02-18
Sponsor
Gottheimer, Josh (D-New Jersey)
Official Source
Investability
29/100
Stage
COMMITTEE
Related Bills
0
Full Text
943 chars
Alive
Yes

What This Bill Does · Plain English

Summary · Congress.gov
Cameron's Law This bill increases the orphan drug tax credit to 50% (from 25%) of qualified clinical testing expenses paid or incurred in the development of drugs to treat certain rare diseases or conditions. As background, the Tax Cuts and Jobs Act reduced the orphan drug tax credit (for tax years after 2017) to 25% of qualified clinical testing expenses (e.g., wages, supplies, and certain contract expenses) paid or incurred in the development of drugs to treat certain rare diseases or conditions. For 2017 and prior tax years, the orphan tax credit was 50% of such expenses paid or incurred.

Action Timeline

2025-02-18
Referred to the House Committee on Ways and Means.
2025-02-18
Introduced in House
2025-02-18
Introduced in House

Frequently Asked Questions

Did HR.1414 pass?
HR.1414 is still alive. Current stage: COMMITTEE. Pass likelihood: 29%.
What does HR.1414 do?
Cameron's Law This bill increases the orphan drug tax credit to 50% (from 25%) of qualified clinical testing expenses paid or incurred in the development of drugs to treat certain rare diseases or conditions. As background, the Tax Cuts and Jobs Act reduced the orphan drug tax credit (for tax years after 2017) to 25% of qualified clinical testing expenses (e.g., wages, supplies, and certain contract expenses) paid or incurred in the development of drugs to treat certain rare diseases or conditions. For 2017 and prior tax years, the orphan tax credit was 50% of such expenses paid or incurred.
Who sponsored HR.1414?
HR.1414 was sponsored by Josh Gottheimer (D-New Jersey).

Full Bill Text

119 HR 1414 IH: Cameron’s Law U.S. House of Representatives 2025-02-18 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 1st Session H. R. 1414 IN THE HOUSE OF REPRESENTATIVES February 18, 2025 Mr. Gottheimer (for himself, Mr. Bacon , Mr. Panetta , and Mr. Suozzi ) introduced the following bill; which was referred to the Committee on Ways and Means A BILL To amend the Internal Revenue Code of 1986 to restore the amount of the orphan drug tax credit. 1. Short title This Act may be cited as Cameron’s Law . 2. Restoration of amount of orphan drug tax credit (a) In general Section 45C(a) of the Internal Revenue Code of 1986 is amended by striking 25 percent and inserting 50 percent . (b) Effective date The amendment made by this section shall apply to taxable years beginning after the date of the enactment of this Act.
🔒 GovGreed Pro · Trading Intelligence on HR.1414 Get Access — $24.50/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated 2026-09-14. Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records. GovGreed is not affiliated with the U.S. Government. Not financial advice. [live render]